Doxorubicin hydrochloride Injection 50 mg in 25 mL (17)

Држава: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

doxorubicin hydrochloride, Quantity: 2 mg/mL

Доступно од:

Pfizer (Perth) Pty Ltd

Фармацеутски облик:

Injection, solution

Састав:

Excipient Ingredients: sodium chloride; hydrochloric acid; water for injections

Пут администрације:

Intravenous

Јединице у пакету:

1 x 25 mL

Тип рецептора:

(S1) This Schedule is intentionally blank

Терапеутске индикације:

Doxorubicin HCl is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. acute lymphoblastic leukemia acute myeloblastic leukemia Hodgkin lymphoma non-Hodgkin lymphoma metastatic breast cancer metastatic Wilms? tumor metastatic neuroblastomas metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma

Резиме производа:

Visual Identification: Clear and clean red solution, practically free from visible particles.; Container Type: Vial; Container Material: PP; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус ауторизације:

Listed (Export Only)

Датум одобрења:

2019-05-01